Orthofix International reported $-2.22M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Accuray USD 2.54M 6.49M Dec/2024
AngioDynamics USD -6.35M 4.55M Sep/2025
Artivion USD 2.42M 4.07M Dec/2025
AtriCure USD 4.06M 4.89M Sep/2026
Dexcom USD 249.1M 49.6M Jun/2026
EDAP TMS EUR -9.08M 4.07M Mar/2026
Globus Medical USD 141.17M 10.4M Sep/2026
Inogen USD -5.96M 373K Sep/2024
Insulet USD 141.1M 46.1M Sep/2026
Integra LifeSciences USD 14.85M 10.37M Sep/2026
J&J USD 210M 5.32B Sep/2026
Medtronic USD 1.47B 227M Jun/2026
Mesa Laboratories USD -1.68M 5.1M Dec/2024
Orthofix International USD -2.22M 20.57M Dec/2025
Plus Therapeutics USD -6.95M 1.23M Mar/2026
Smith & Nephew USD 303M 10M Jun/2026
STAAR Surgical USD 5.58M 2.48M Sep/2026
Stryker USD 1.28B 531M Jun/2026
Tandem Diabetes Care USD -7.08M 14.08M Sep/2026
Teleflex USD 927.43M 827.73M Sep/2026
Veracyte USD 31.5M 6.01M Sep/2026
Zimmer Biomet Holdings USD 191.6M 6.7M Sep/2026